<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-5WH5FIJC</identifier><date>2012</date><creator>Milanez, Tomaž</creator><creator>Šeruga, Boštjan</creator><creator>Škrbinc, Breda</creator><creator>Zadnik, Vesna</creator><creator>Žist, Andrej</creator><relation>documents/doc/5/URN_NBN_SI_doc-5WH5FIJC_001.pdf</relation><relation>documents/doc/5/URN_NBN_SI_doc-5WH5FIJC_001.txt</relation><format format_type="volume">16</format><format format_type="issue">2</format><format format_type="type">article</format><format format_type="extent">str. 74-77, 113</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">1421435</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-5WH5FIJC</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Bladder neoplasms</subject><subject language_type_id="eng">Chemotherapy, adjuvant</subject><subject language_type_id="eng">Cystectomy</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="slv">neoadjuvantna kemoterapija</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">sečni mehur</subject><title>Spregledana korist neoadjuvantne kemoterapije v zdravljenju mišično invazivnega raka sečnega mehurja</title></Record>